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Aims: To identify age and gender stratified normative values for the International Prostate 
Symptom Score (IPSS) for older community-living adults.  
Methods: Secondary analysis of data from a large cohort study produced norms presented as 
means, standard deviations, medians, ranges and percentile scores. Non-parametric analyses 
were conducted to investigate the effect that demographic variables, smoking status and 
comorbidity had on the severity of Lower Urinary Tract Symptoms (LUTS) as measured by the 
IPSS.  
Results: Data from a total of 1103 survey respondents of community-living men and women 
aged between 60 and 99 years in the UK were analysed. Normal ranges for the IPSS (as 
indicated by the median and 25th to 75th percentiles) were within the mild and low moderate 
LUTS categories of the IPSS, irrespective of age or gender. Age, gender, co-habitant status and 
comorbidity had an effect on LUTS severity with comorbidity being the best predictor of IPSS 
scores.  
Conclusion: This study has provided IPSS normative values for an older UK adult population 
aged 60-99 years. These normative values can be used by researchers and practitioners for peer 
comparison making the individual’s IPSS score more meaningful. Presenting the normative 
values suggests that some mild symptoms may be described as ‘normal’. It may also help to 
combat the perception that poor bladder health is an inevitable part of ageing, as all norms in 
the current study fell into either mild or low moderate symptom categories. 











Lower urinary tract symptoms (LUTS) are subjective markers of a disease or change in condition 
defined from the individual’s (patient, carer or partner) perspective. They are divided into three 
categories by the International Continence Society (ICS) definition,1 storage, voiding and post 
micturition symptoms. Both LUTS and Urinary Incontinence (UI) are highly prevalent among 
men and women above the age of forty. There has been a rise in global prevalence of LUTS and 
UI with an estimated 2.3 billion people reporting a minimum of one LUTS, and 348 million 
people reporting UI by 2018.2 
Prevalence of LUTS and UI increases with age,2 and has detrimental effects on health-related 
quality of life (QOL3). Although LUTS are usually treatable, people who experience them are 
often reluctant to seek help. Previous research has found that there are several barriers to 
help-seeking behaviour relating to urinary problems including: issues of social stigmatisation,4 
embarrassment, poor knowledge regarding symptoms and treatments, and perceptions that 
LUTS are an inevitable part of ageing.5-6   
However, active screening for LUTS could prompt early conversations about bladder health, 
impact and treatment seeking. Such screening may result in raised awareness and knowledge 
about LUTS and how to self-manage them, which has the potential to improve symptoms and 
associated health-related QOL.  
The International Prostate Symptom Score (IPSS) questionnaire is a brief (8-item), self-report 
screening measure of LUTS (7-items) and associated QOL (1-item). The IPSS was originally 
known as the American Urological Association Symptom Index (AUASI). It was developed by 
Barry and colleagues7 to screen for benign prostatic hyperplasia. Although originally developed 
for use with men, the IPSS has been found to be a valid and reliable screening tool for LUTS in 
both men and women8-9 and is widely used in clinical practice and research.10  
The IPSS score ranges from 0 to 35 with higher scores indicating worse symptoms. Cut-off 
scores in the IPSS are currently used to interpret the overall severity of reported LUTS whereby: 
scores between 1 and 7 are considered mild symptoms; 8-19 moderate symptoms, and 20-35 
severe symptoms. Several reports have found the individual symptom items within the IPSS to 
have acceptable levels of internal consistency8-9 therefore justifying the questions being 
combined in an overall score. An alternative approach however is to regard LUTS as a 
dimensional rather than a categorical construct by considering a total IPSS score in relation to 
normative values produced from a comparative general population.   
Normative values could be used to help facilitate clinicians and researchers interpretations of 
IPSS results in relation to group norms, as comparisons can be made between an individual’s 
score and the normative score of a larger sample of people, according to their specific 
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demographic details. This comparison allows for a judgement to be made, or to raise 
awareness, about a person’s level of bladder health at a particular point in time.  
Normative values for the IPSS have previously been produced for German community living 
males aged 50 years and older.11 The current study sought to address the lack of IPSS normative 
values for community living older males and females aged sixty years and over living in the UK.  
The aims of the study were, for older community-living adults in the UK, to: i) provide 
normative values for the IPSS; ii) investigate the influence of demographic variables, smoking 
status and comorbidity on IPSS scores.  
Material & Methods 
Study Design 
The current study formed a secondary analysis of data from a cross-sectional survey of LUTS 
experienced by older adults, which primarily focused on experiences of nocturia12. The primary 
study was not originally designed to collect data for the production of normative values, 
however the dataset included data that met the criteria for the current study, namely: LUTS 
were self-reported by older, community-living adults who were not seeking healthcare, using 
standardised tools including the IPSS. Therefore the use of this previously unmined dataset, in 
respect of normative values, is seen as an efficient use of available data.  
Data Collection 
The primary survey study12 involved sending all adults, aged 60 years and over, from two GP 
practices a structured questionnaire to anonymously self-complete and return by post. The 
questionnaire captured data on the older person’s demographic details, health and physical 
status, presence of LUTS (this included the 7 IPSS symptom items), continence status, nocturia 
specific quality of life (ICI N-QoL13), lifestyle factors, health behaviours and help-seeking 
behaviours. For the purposes of this secondary data analysis the demographic, health and IPSS 
data were used.   
Measures  
The IPSS consists of 7 LUTS questions which target different types of storage, voiding and post-
micturition LUTS including: Incomplete emptying, Frequency, Intermittency, Urgency, Weak 
Stream, Straining, and Nocturia. Each question is scored on a Likert-type scale ranging from 0 
(Not at all) to 5 (Almost always) with the exception of the Nocturia question, which records the 
person’s typical number of rises to void over the previous month, from the time they went to 
bed until the time they got up in the morning: 0 (None) to 5 (5 times or more). The 7 separate 
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scores are added to produce an overall score (range: 0–35). The overall score is then converted 
into a LUTS severity category of either: Mild (1-7), Moderate (8-19) or Severe (20-35).  
Analysis  
Graphical inspection of the distribution of IPSS total scores indicated that the scale was 
positively skewed. A Kolmogorov–Smirnov test confirmed that the distributions deviated 
significantly from a normal distribution, D(1029) =0.17, p<.001. No extreme outliers were 
identified in the preliminary analysis. Due to non-normal distribution of scores, non-parametric 
tests were used for analysis, where applicable.  
Demographic information was extracted from the data set including: age, gender, ethnicity and 
co-habitation status. Smoking status and the number of comorbidities were also obtained for 
each respondent as these two variables have been found to be potential risk factors for the 
presence of LUTS.14 
Data were analysed using SPSS-23. In order to produce a normative set of IPSS values, means, 
medians, ranges and standard deviations (SD) were calculated for each item on the IPSS and 
total scores. Percentile ranges (25-75) were also calculated for total IPSS scores. All calculations 
were stratified for age and gender.  
Spearman’s rho coefficient correlation was used to measure the correlation between IPSS total 
scores and age. The Mann-Whitney U test was used to test for differences in IPSS total scores 
according to gender, smoking status, and co-habitant status. The Kruskal–Wallis test was used 
to identify differences in IPSS scores according to the number of health conditions reported, 
ethnicity and categorical age. Lastly, multiple regression analysis was conducted to investigate 
which of the independent variables were associated with total IPSS scores.  
Results 
A total of 1362 questionnaires were returned from the 2946 sent (46%) of which 1103 were 
analysed. Data from 259 respondents could not be analysed as information relating to age and 
gender was missing. The mean age of the total sample (1103 respondents aged 60 years and 
over) was 70 years, SD = 8 (median age 69 years; range 60 to 99 years). 
Table 1 provides basic descriptive and health condition data for the normative sample.  
Thirty percent of the sample was amongst the youngest older adults, whereas only 15% were 
amongst the oldest older adults, displaying a difference in respondent group sizes.  Differences 
of this type are expected in surveys as they reflect the demography of the general population, 
that is, there are  more ‘younger’ older adults than ‘older’ older adults and therefore the 
response rates obtained reflected these age ranges (see Table 1).  
5 
 
Forty seven percent of the sample was male, 34% lived alone, 99% were Caucasian and 14% 
were smokers. The health conditions reported included: high blood pressure; heart failure; 
angina; breathlessness; diabetes; depression/anxiety, and other. The majority of respondents 
(61%) reported that they experienced between 1 and 2 health conditions, with a further 15% 
reporting 3 or more conditions. However, most respondents still considered themselves to be 
in good or very good health (73%).  
 
[insert Table 1 here] 
 
Normative Data for IPSS 
 
Tables of normative scores (Means, medians, ranges and SDs) for each IPSS item and total 
scores were produced, categorised by gender, age group, and for the total group (Table 2).   
[insert Table 2 here] 
 
Figure 1 illustrates that males reported higher IPSS scores than females for most age groups. 
Total IPSS for both males and females increase from the youngest age category (60-64 years) to 
the oldest age category (80 years and over). Notably, male scores appeared to increase with 
age in a more linear fashion than females.  
 
[insert figure 1 here] 
 
Median scores and the interquartile range of normative IPSS scores for males and females are 
presented in Figure 2. The graphs illustrate that three quarters of the respondents scored less 
than 15, meaning that the majority, irrespective of age, would be classified as having mild or 
moderate symptoms.   
 
[insert figure 2 here] 
 
LUTS, age, gender, smoking, ethnicity and co-habitation 
 
There was a weak, positive correlation between LUTS and age, r= .122, n = 1006, p < .001, with 
higher IPSS scores associated with older age. There was a statistically significant difference in 
IPSS scores according to categorical age, χ² (4, n = 1006) = 15.56, p = .004. Total IPSS scores of 
respondents aged 60-64 years, were significantly lower than total IPSS scores of respondents 
aged 80 years and over, U = 17879, z = -3.23, p = .001, r = .2 (small effect). These results imply 




Male scores on the IPSS were significantly higher than female scores on the IPSS, U = 114723, z 
= -2.85, p = .004, r = .09. There was no significant difference in the IPSS scores of smokers and 
non-smokers, U = 60198, z = -.45, p = .655, r = .01. People who live alone had significantly 
higher IPSS scores than people who co-inhabit, U = 100658, z = -2.85, p = .004, r = .09. No 
significant difference was seen in the IPSS total scores between people from different ethnic 
backgrounds, χ² (2, n = 1009) = .9, p = .637. 
 
LUTS and health conditions 
 
There was a statistically significant difference in IPSS scores according to the number of 
additional health conditions reported, χ² (3, n = 1029) = 64.79, p < .001.  
 
The median IPSS scores increased as the number of additional health conditions reported 
increased (Group 1: no health conditions Md = 4, Group 2: 1-2 health conditions Md = 5, Group 
3: 3-4 health conditions Md = 8, Group 4:  5 or more health conditions Md = 17.5). Statistically 
significant differences were evident between Group 1 and the other 3 groups, after the 
Bonferroni adjusted significance threshold of 0.017 was made. Group 2 IPSS scores were 
significantly higher than Group 1, U = 62828, z = -4.51, p < .001, r = .2 (small effect). Group 3 
IPSS scores were significantly higher than Group 1, U = 9336, z = -7.38, p < .001, r = 0.4 (medium 
effect). Group 4 IPSS results were also significantly higher than Group 1, U = 563, z = -3.64, p < 
.001, r = .2 (small effect). These results imply that the more health conditions someone has, the 
more likely they are to experience LUTS.   
 
Predicting IPSS scores 
 
A multiple linear regression analysis was conducted to identify the variables most strongly 
associated with the IPSS total scores. Four independent variables which were found to be 
significant on univariate analyses were added to the model, namely age category, gender, co-
habitant status and number of reported health conditions. The model explained 9.3% of the 
variance in IPSS total scores. The strongest predictor of IPSS scores was number of other health 
conditions (Beta = .26, p < .001) which uniquely explained 7% of the total variance in IPSS total 
scores.  Gender and co-habitant status were also significant predictors of IPSS scores (Beta = -.1, 
p = .001; Beta -.08, p = .014 respectively). Age was marginally non-significant as a predictor of 
total IPSS scores (Beta = .06, p = .051).  
 
Discussion 
The primary aim of this study was to produce IPSS normative values for older adults living in the 
UK. Normative data has been presented in terms of means, SDs, ranges, medians, and 
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interquartile ranges, broken down by age (60-64 years, 65-69 years, 70-74 years, 75-79 years, 
and 80 years and over) and gender. This is the first IPSS normative values set for older adults 
living in the UK.  
These norms will be useful for researchers and practitioners, as individual IPSS scores can be 
used for peer comparison, making the scores more meaningful to the individual. If the 
individual can see how they compare with their peers, this will give them greater awareness of 
whether their score is out-with or within the norms in accordance with their age and gender. 
This could put an individual’s mind at ease or encourage them to seek help for their symptoms. 
The use of normative values for comparison has been suggested to be an effective behaviour 
change technique15-16 and is reported to be acceptable and useful by older adults.17  The 
published IPSS severity categories and cut-off scores are currently identical irrespective of the 
respondent’s age and gender.7 When used on an individual basis the IPSS simply makes the 
person aware of what category they fall into (mild, moderate, or severe). However, using the 
comparative normative data set could help to combat the perception that poor bladder health 
is an inevitable part of ageing, as the norms found in the current study did not fall into the 
severe symptom category. It is clear however, that there is some decline in bladder health in 
older adults as it was common to have mild or low-moderate LUTS in this population and the 
findings raise the possibility that such deterioration is ‘normal’, for both men and women. 
Similar results were found in a study by Berges and Oelke11 who suggest IPSS scores of 
community-dwelling men living in Germany aged 50-80 years increased with age. They found 
that Mean total IPSS scores increased from 3 (youngest age group) to 7 (oldest age group), but 
scores still remained out-with the severe category of LUTS.  
A secondary aim of this study was to investigate the influence of several variables on IPSS 
scores. Gender, age, co-habitant status and co-morbidity had an effect on total IPSS scores. 
Males were found to have higher scores than females on the IPSS, demonstrating that men 
experience worse LUTS than women. These findings are similar to a previous survey study 
which informed that men reported more symptoms than women for the majority of the IPSS 
questions among the older age-groups.10 
This study found that ethnicity had no significant impact on IPSS scores however these results 
should be treated with caution due to the sample being predominantly from a Caucasian 
population. A previous US study by Coyne and colleagues18 which estimated the prevalence of 
LUTS and Overactive Bladder, found that there were racial/ethnic group differences in relation 
to the prevalence of LUTS. The Coyne19 study had a large, representative sample of each of the 
ethnic groups in the targeted population. We suggest therefore, that the findings by Coyne and 
colleagues are more reliable than our own in regards to ethnicity.  
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Smoking has been found to be an associated risk factor for LUTS.14 In contrast, no differences in 
IPSS scores were found between smokers and non-smokers in the current study. Notably, our 
sample of smokers was very small (n = 148) in comparison to the number of non-smokers (n = 
971) and therefore our results should again be treated with caution.   
Of all the variables analysed, the strongest predictor of IPSS was co-morbidity: as the number of 
other health conditions increased, the IPSS total scores increased, indicating higher severity of 
LUTS. These results support findings from previous studies, that co-morbid conditions are 
significantly associated with the incidence of LUTS.14,19  
Although several risk factors for LUTS have been identified in the current study, they explain 
only a small variance in the severity of LUTS. Most of the factors found to have an effect on 
LUTS severity in this study are non-modifiable. Modifiable risk factors associated with LUTS 
include low levels of physical activity,20 sedentary behaviour21 and obesity.22 Therefore we 
suggest that greater focus is put on these factors in future research, as targeting these lifestyle 
behaviours could provide potential preventative measures for the prevalence and incidence of 
LUTS.  
Screening for LUTS would allow discussion of treatment options and self-management options, 
to prevent further decline in urinary function. With increasing age, declining bladder health is 
associated with avoidance of activity and falls and it is important to address these issues early.23 
It would be useful for future research to explore older people’s views of the IPSS as a screening 
tool for bladder health. 
Limitations:  
Mitrushina and colleagues24 suggest that normative data is of limited use, as it is relevant to 
only people with similar demographic characteristics and who have had the test/questionnaire 
administered in the same way as the sample that was used to produce the norms. We agree 
that our normative data set will only be applicable to community-living older adults in the UK. 
We also have a low number of older people from ethnic minorities. However the normative 
information adds value and provides us with more detail about age and gender norms than was 
previously available. Nevertheless, it would be useful to investigate how the norms that we 
have produced compare with norms for older men and women in other countries, to determine 
whether there are geographical differences in the prevalence of LUTS. Previous research has 
found that the mode of administration of the IPSS does not have an effect on IPSS scores.25  
Conclusion 
This study provides normative data for the IPSS for an adults aged 60 years and over. This 
normative data can be used for peer comparison, providing more meaningful information to 
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the individual. Mild to moderate LUTS are common in older people but severe LUTS should be 
considered unusual into old age and treatment or self-management options offered.   
 
Figure Legends:  
 
Figure 1: International Prostate Symptom Score total scores distribution for men and women aged 60 
years and over.  
 
Figure 2: Median and 25th to 75th percentiles for total scores of the International Prostate Symptom 
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